Szyper-Kravitz, Martine <br/><br/>
Granulocyte colony-stimulating factor administration upregulates telomerase activity in CD34+ haematopoietic cells and may prevent telomere attrition after chemotherapy.  [electronic resource] 

 -  British journal of haematology  Jan 2003 
 - 329-36 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0007-1048 
<br/><br/><label>Standard No.: </label>10.1046/j.1365-2141.2003.04043.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Antigens, CD34<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Bone Marrow Cells--drug effects<br/>Cyclophosphamide--administration & dosage<br/>Doxorubicin--administration & dosage<br/>Enzyme Activation<br/>Granulocyte Colony-Stimulating Factor--pharmacology<br/>Hematopoietic Stem Cell Mobilization<br/>Hematopoietic Stem Cells--drug effects<br/>Humans<br/>Lymphoma--drug therapy<br/>Middle Aged<br/>Prednisone--administration & dosage<br/>Protein Kinase C--genetics<br/>Protein Kinase C-alpha<br/>RNA--analysis<br/>Telomerase--genetics<br/>Telomere--genetics<br/>Vincristine--administration & dosage